Giulia Anderluzzi, Gustavo Lou, Yang Su and Yvonne Perrie* Pages 1 - 16 ( 16 )
Background: Solid lipid nanoparticles offer a range of advantages as delivery systems but they are limited by effective manufacturing processes.
Objective: Within this study we outline a high-throughput and scalable manufacturing process for solid lipid nanoparticles.
Method: The solid lipid nanoparticles were formulated from a combination of Tristearin and 1,2-Distearoyl-phosphatidylethanolamine-methyl-polyethyleneglycol conjugate-2000 and manufactured using the M-110P Microfluidizer® processor (Microfluidics Inc, Westwood, Massachusetts, US).
Results: The manufacturing process was optimized in terms of the number of process cycles (1 to 5) and of process pressure change (20,000, 25,000 and 30,000 psi). The solid lipid nanoparticles were purified using tangential flow filtration, and they were characterized in terms of their size, PDI, Z-potential and protein loading. At-line particle size monitoring was also incorporated within the process train. Our results demonstrate that solid lipid nanoparticles can be effectively manufactured using this process at pressures of 20,000 psi with as little as 2 process passes, with purification and removal of non-entrapped protein achieved after 12 diafiltration cycles. Furthermore, the size could be effectively monitored at-line to allow rapid process control monitoring or product validation.
Conclusion: Using this method, protein loaded solid lipid nanoparticles containing a low (1%) and high (16%) Pegylation were manufactured, purified and monitored for particle size using an AT-line system demonstrating a scalable process for the manufacture of these nanoparticles.
Solid lipid nanoparticles, Microfluidizer processor, High-throughput manufacturing, protein delivery
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, Microfluidics International Corporation, Westwood, Massachusetts, 022090, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE